D/B/A Centerspace Common Stock (NY:CSR)

56.61 -0.33 (-0.58%)

Official Closing Price Updated: 7:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about D/B/A Centerspace Common Stock

< Previous 1 2 3 4 Next >

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023 ↗

May 02, 2023

Via Benzinga

Around $3M Bet On This Communication Services Stock? Check Out These 3 Stocks Insiders Are Buying ↗

April 03, 2023

Although US stocks closed higher on Friday, there were a few notable insider trades.

Via Benzinga

The 3 Best-Performing Residential REITs Over The Past 4 Weeks ↗

January 30, 2023

Residential real estate investment trusts (REITs) were subpar performers in 2022, but like many other REITs, they are beginning to find their footing in 2023, as the entire residential subsector has...

Via Benzinga

Residential REIT Centerspace: From $107.50 to $60.16 In 12 Months ↗

December 20, 2022

Shares of residential real estate investment trust (REIT) Centerspace (NYSE: CSR) sold with extraordinarily heavy volume and touched a brand new 52-week low.

Via Benzinga

Where Centerspace Stands With Analysts ↗

December 14, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Centerspace ↗

December 14, 2022

Via Benzinga

4 Analysts Have This to Say About Centerspace ↗

November 23, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Centerspace ↗

November 02, 2022

Within the last quarter, Centerspace (NYSE:CSR) has observed the following analyst ratings:

Via Benzinga

Earnings Scheduled For May 1, 2023 ↗

May 01, 2023

Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.

Via Benzinga

A Preview Of Centerspace's Earnings ↗

February 20, 2023

Via Benzinga

4 Analysts Have This to Say About Centerspace ↗

November 02, 2022

Within the last quarter, Centerspace (NYSE:CSR) has observed the following analyst ratings:

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 21, 2023

On Tuesday, 74 companies achieved new lows for the year.

Via Benzinga

Another REIT Drops To 52-Week New Low ↗

November 02, 2022

Less-than-expected funds from operations (FFO) in the third quarter led to a new 2022 low for Centerspace (NYSE: CSR), a small New York Stock Exchange real estate investment trust (REIT).

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022 ↗

November 02, 2022

Upgrades

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

Earnings Scheduled For February 28, 2022 ↗

February 28, 2022

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022 ↗

August 04, 2022

Upgrades

Via Benzinga

Earnings Scheduled For October 31, 2022 ↗

October 31, 2022

Companies Reporting Before The Bell • Insperity (NYSE:NSP) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.46 billion.

Via Benzinga

Earnings Scheduled For August 1, 2022 ↗

August 01, 2022

Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.

Via Benzinga

What 4 Analyst Ratings Have To Say About Centerspace ↗

July 20, 2022

Over the past 3 months, 4 analysts have published their opinion on Centerspace (NYSE:CSR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Piper Sandler Maintains Overweight Rating for Centerspace: Here's What You Need To Know ↗

June 21, 2022

Piper Sandler has decided to maintain its Overweight rating of Centerspace (NYSE:CSR) and lower its price target from $110.00 to $100.00. Shares of Centerspace are trading up 1.29% over the last 24...

Via Benzinga

Earnings Preview: Centerspace ↗

April 29, 2022

Centerspace (NYSE:CSR) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Centerspace will...

Via Benzinga

REIT Stocks Keep Movin' On Up As Apartment Rents Surge After Covid Crash ↗

November 05, 2021

REIT stocks provide investors access to rental markets as they rebound from pandemic lows.

Via Investor's Business Daily

The Latest Barron's Picks And Pans Include General Electric, Netflix, Reddit And More ↗

September 04, 2021

This weekend's Barron's reveals what market strategists recommend for a stock market that likely will struggle this fall. Other featured articles discuss biotech stocks...

Via Benzinga

Earnings Scheduled For May 2, 2022 ↗

May 02, 2022

Companies Reporting Before The Bell • New Gold (AMEX:NGD) is estimated to report quarterly earnings at $0.03 per share on revenue of $212.42 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2022 ↗

March 11, 2022

Upgrades According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ:SBRA) was changed from Underperform to Neutral. In the fourth quarter, Sabra...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 ↗

December 10, 2021

Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:

Via Benzinga

Earnings Scheduled For November 1, 2021 ↗

November 01, 2021

Companies Reporting Before The Bell • ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter. • Kiniksa Pharmaceuticals (NASDAQ:...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.